UF Pharmacy Professor’s Paper Ranks No. 2 in Citations This Century
A paper co-authored by UF researcher Thomas Schmittgen has become the second most-cited research article of the 21st century and the fifth most-cited of all time, with nearly 150,000 citations, according to Nature.
Popular Diabetes Medications May Protect Against Alzheimer’s Disease, UF Researchers Find
UF researchers have found that a pair of popular glucose-lowering medications may have protective effects against the development of Alzheimer’s disease and related dementias in patients with Type 2 diabetes.
UF Professor Develops AI Tool To Better Assess Parkinson’s Disease, Other Movement Disorders
Diego Guarin, Ph.D., has developed an open-source computer program called VisionMD, which uses artificial intelligence to analyze videos of patients with Parkinson's disease and other movement disorders.
Atsena Therapeutics Granted U.S. FDA Regenerative Medicine Advanced Therapy Designation for ATSN-201 Gene Therapy To Treat X-Linked Retinoschisis
UF startup Atsena Therapeutics announced that the U.S. FDA has granted Regenerative Medicine Advanced Therapy designation for ATSN-201 for the treatment of X-linked retinoschisis.
LightPath Technologies Awarded Initial $2.2 Million IR Camera Order for U.S. Navy Shipboard Optics (SPEIR) Program
UF startup LightPath Technologies announced its acquired subsidiary G5 Infrared has been awarded an initial $2.2 million engineering development model (EDM) order for infrared cameras by L3Harris Technologies.
Rise Therapeutics Reports Ulcerative Colitis Dose Escalation Clinical Results for R-3750 at the Digestive Disease Week (DDW) Conference in San Diego May 3–6
UF startup Rise Therapeutics announced that it will report its first clinical results from the completed dose escalation segment of its R-3750 Phase 1 clinical trial in ulcerative colitis at the upcoming DDW conference.
Applying AI to Cancer Research, a UF Professor Helps Transform Medical Imaging
UF researchers are developing AI algorithms for a range of medical image analysis tasks, such as multimodal image fusion, cancer detection, organ segmentation, and enhanced image resolution for diagnosis.
Atsena Therapeutics Announces Oversubscribed $150 Million Series C Financing To Further Advance Ocular Gene Therapy Programs
UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on reversing or preventing blindness, announced the successful close of an oversubscribed $150 million Series C financing round.
Ruchkin Receives NSF CAREER Award To Make Cyber-Physical Systems Aware of Their Limitations
UF researcher Ivan Ruchkin has received NSF CAREER Award to improve the safety of cyber-physical systems by developing methods to explicitly discover, validate, and manage the underlying assumptions that drive their behavior.
Using Generative AI To Engineer Enzymes, UF Researchers Help Transform Biotechnology
UF researchers are on a mission to transform biotechnology and improve the way genetic disorders are treated, with help from generative artificial intelligence, or AI, and a U.S. Department of Defense grant.
